Ertugliflozin, a SGLT-2 Inhibitor, Guards Against Thioacetamide-induced Liver Fibrosis: The Nrf2/HO-1 and TLR4/ TGF-β1 Pathways
Hepatic fibrogenesis is considered an epidemic health problem since it can lead to several insults that can be fatal. Ertugliflozin (Ertu), an inhibitor of the sodium-glucose cotransporter-2 (SGLT2), is one of the most recent anti-diabetic medications used to treat type 2 diabetes mellitus (T2DM). I...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Egyptian Society for Animal Management
2025-07-01
|
| Series: | Journal of Applied Veterinary Sciences |
| Subjects: | |
| Online Access: | https://javs.journals.ekb.eg/article_427566_1a0899141f42a13bc934cb5aecc25164.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|